Showing results (131-140 of 557) with videos related to
Sort By:
Pageof 56
The American Journal of Surgical Pathology|May 14, 2011
Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expressionMartin Hasselblatt, Stefan Gesk, Florian Oyen, et al.Genes, Chromosomes & Cancer|October 18, 2012
High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumorsMartin Hasselblatt, Sarah Isken, Anna Linge, et al.Brain Pathology (Zurich, Switzerland)|June 27, 2015
Papillary Tumor of the Pineal Region: A Distinct Molecular EntityStephanie Heim, Martin Sill, David T W Jones, et al.Journal of Neuro-Oncology|January 17, 2009
Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAILDolly G Aguilera, Chandra M Das, Neeta D Sinnappah-Kang, et al.The Journal of Urology|October 18, 2015
Sexual Function, Social Integration and Paternity of Males with Classic Bladder Exstrophy following Urinary DiversionPeter Rubenwolf, Christian Thomas, Joachim W Thüroff, et al.The Journal of Urology|January 24, 2016
Sexual Function and Fertility of Women with Classic Bladder Exstrophy and Continent Urinary DiversionPeter Rubenwolf, Christian Thomas, Joachim W Thüroff, et al.American Journal of Human Genetics|February 9, 2010
Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndromeReinhard Schneppenheim, Michael C Frühwald, Stefan Gesk, et al.Acta Neuropathologica|March 23, 2021
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymomaChristian Thomas, Felix Thierfelder, Malte Träger, et al.International Journal of Cancer|July 1, 2010
Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastomaJanna Paulsson, Maja Bradic Lindh, Malin Jarvius, et al.Neuro-Oncology|September 17, 2024
Constitutional mosaicism of pathogenic variants in SMARCB1 in a subset of patients with sporadic rhabdoid tumorsLara S Fleischmann, Karolina Nemes, Selina Glaser, et al.Pageof 56